“Combined use of immunohistochemical markers of basal and luminal subtypes in urothelial carcinoma of the bladder: Association with clinicopathological features and outcomes”, Clinics, vol. 76, p. e2587, Mar. 2022, doi: 10.6061/clinics/2021/e2587.